Vitamin E Vitamin E


DEA Gives Cannabis Law a Significant Tweak

The DEA has stepped in and cracked down on marijuana extracts. The target of this increased regulation would appear to be the burgeoning cannabidoil (CBD) market. Yahoo News reports that CBD will now be classified as a Schedule 1 drug and is in the same category as LSD and heroin.

Marijuana, or cannabis, has been used for at least 5,000 years and has an extensive history of traditional uses as an industrial material and a botanical medicine all throughout Asia, Africa, Europe, and America.

The term “medical marijuana” refers to the use of the whole, unprocessed marijuana plant and its pure extracts to treat a disease or improve a symptom. It must be sourced from a medicinal-grade cannabis plant that has been meticulously grown without the use of toxic pesticides and fertilizers.

Marijuana’s incredible healing properties come from its high cannabidiol (CBD) content and critical levels of medical terpenes and flavonoids. It also contains some tetrahydrocannabinol (THC), the molecule that gives the psychoactive effect, which most recreational users are after. Through traditional plant breeding techniques and seed exchanges, growers have started producing cannabis plants that have higher levels of CBD and lower levels of THC for medical use.

Although the Food and Drug Administration (FDA) has not yet approved medical marijuana, more and more physicians are starting to reverse their stand on the issue and swear by its effectiveness and health benefits. Changing CBD to a Schedule 1 drug throws a serious wrench in the works and could have a calamitous health impact on those who rely on the potential curative properties of cannabidoil. It is disheartening that something as promising as CBD is being demonized due to bureaucrats with vested interests in the pharmaceutical industry.
Click Here and be the first to comment on this article
Post your comment